Ryoko Inaba Higashiyama

Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression

Ken Masuda, Hidehito Horinouchi, Midori Tanaka et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 93 citations · Full text

Medicine, Oncology, Pharmacology +17

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

Tohru Ohnuma, Aiko Toda, Ayako Kimoto et al. · Clinical Interventions in Aging · 2016 · 80 citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia

Narimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima et al. · Schizophrenia Bulletin · 2014 · 41 citations · Full text

Medicine, Pharmacology, Psychiatry +15

Passive Smoking–Induced Mutagenesis as a Promoter of Lung Carcinogenesis

Akifumi Mochizuki, Kouya Shiraishi, Takayuki Honda et al. · Journal of Thoracic Oncology · 2024 · 26 citations · Full text

Medicine, Genetics, Molecular Biology +11

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia

Mayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi et al. · Neuroscience Letters · 2015 · 24 citations · Full text

Medicine, Molecular Medicine, Psychiatry +6